Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1990 Jun 16;300(6739):1548–1551. doi: 10.1136/bmj.300.6739.1548

Purpura and dermal thinning associated with high dose inhaled corticosteroids.

S Capewell 1, S Reynolds 1, D Shuttleworth 1, C Edwards 1, A Y Finlay 1
PMCID: PMC1663083  PMID: 2372620

Abstract

OBJECTIVE--To assess the effect of high dose inhaled corticosteroids on skin. DESIGN--Cross sectional study of patients receiving treatment for chest diseases. SETTING--Outpatient chest clinic in a teaching hospital. PATIENTS--68 Patients divided into four groups of similar age--namely, 15 receiving long term oral prednisolone, 21 receiving high dose inhaled corticosteroids, 15 receiving low dose inhaled corticosteroids, and 17 controls. MAIN OUTCOME MEASURES--Skin thickness at three sites measured by A scan ultrasound and clinical assessment of purpura. RESULTS--Compared with controls patients in both the oral prednisolone treated group and the high dose inhaled corticosteroid treated group had significantly thinner skin at all three sites (group median thicknesses: prednisolone treated group 28-33% less than controls; high dose inhaled corticosteroid treated group 15-19% less than controls). Differences in skin thicknesses between the low dose inhaled corticosteroid treated group and the controls were trivial. The prevalence of purpura was significantly greater in patients receiving oral prednisolone (12/15 patients) and high dose inhaled corticosteroids (10/21) than in controls (2/17). CONCLUSION--Skin thinning and purpura represent further evidence of systemic effects of high dose inhaled corticosteroids.

Full text

PDF
1548

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boyle J., MacKie R. M., Briggs J. D., Junor B. J., Aitchison T. C. Cancer, warts, and sunshine in renal transplant patients. A case-control study. Lancet. 1984 Mar 31;1(8379):702–705. doi: 10.1016/s0140-6736(84)92221-9. [DOI] [PubMed] [Google Scholar]
  2. David D. J. Skin trauma in patients receiving systemic corticosteroid therapy. Br Med J. 1972 Jun 10;2(5814):614–616. doi: 10.1136/bmj.2.5814.614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dykes P. J., Marks R. An appraisal of the methods used in the assessment of atrophy from topical corticosteroids. Br J Dermatol. 1979 Nov;101(5):599–609. doi: 10.1111/j.1365-2133.1979.tb11894.x. [DOI] [PubMed] [Google Scholar]
  4. Gaddie J., Petrie G. R., Reid I. W., Skinner C., Sinclair D. J., Palmer K. N. Aerosol beclomethasone dipropionate: a dose-response study in chronic bronchial asthma. Lancet. 1973 Aug 11;2(7824):280–281. doi: 10.1016/s0140-6736(73)90788-5. [DOI] [PubMed] [Google Scholar]
  5. Gottlieb N. L., Penneys N. S. Spontaneous skin tearing during systemic corticosteroid treatment. JAMA. 1980 Mar 28;243(12):1260–1261. [PubMed] [Google Scholar]
  6. Karim A. K., Thompson G. M., Jacob T. J. Steroid aerosols and cataract formation. BMJ. 1989 Oct 7;299(6704):918–918. doi: 10.1136/bmj.299.6704.918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Kruszynska Y. T., Greenstone M., Home P. D., Cooke N. J. Effect of high dose inhaled beclomethasone dipropionate on carbohydrate and lipid metabolism in normal subjects. Thorax. 1987 Nov;42(11):881–884. doi: 10.1136/thx.42.11.881. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Littlewood J. M., Johnson A. W., Edwards P. A., Littlewood A. E. Growth retardation in asthmatic children treated with inhaled beclomethasone dipropionate. Lancet. 1988 Jan 16;1(8577):115–116. doi: 10.1016/s0140-6736(88)90310-8. [DOI] [PubMed] [Google Scholar]
  9. Maxwell D. L., Webb J. Adverse effects of inhaled corticosteroids. BMJ. 1989 Mar 25;298(6676):827–828. doi: 10.1136/bmj.298.6676.827-d. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. McLeod D. T., Capewell S. J., Law J., MacLaren W., Seaton A. Intramuscular triamcinolone acetonide in chronic severe asthma. Thorax. 1985 Nov;40(11):840–845. doi: 10.1136/thx.40.11.840. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Reid D. M., Nicoll J. J., Smith M. A., Higgins B., Tothill P., Nuki G. Corticosteroids and bone mass in asthma: comparisons with rheumatoid arthritis and polymyalgia rheumatica. Br Med J (Clin Res Ed) 1986 Dec 6;293(6560):1463–1466. doi: 10.1136/bmj.293.6560.1463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Shuttleworth D., Marks R., Griffin P. J., Salaman J. R. Dysplastic epidermal change in immunosuppressed patients with renal transplants. Q J Med. 1987 Jul;64(243):609–616. [PubMed] [Google Scholar]
  13. Smith M. J., Hodson M. E. Effects of long term inhaled high dose beclomethasone dipropionate on adrenal function. Thorax. 1983 Sep;38(9):676–681. doi: 10.1136/thx.38.9.676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Smith M. J., Hodson M. E. High-dose beclomethasone inhaler in the treatment of asthma. Lancet. 1983 Feb 5;1(8319):265–269. doi: 10.1016/s0140-6736(83)91686-0. [DOI] [PubMed] [Google Scholar]
  15. Smith M. J. The place of high-dose inhaled corticosteroids in asthma therapy. Drugs. 1987 May;33(5):423–429. doi: 10.2165/00003495-198733050-00001. [DOI] [PubMed] [Google Scholar]
  16. Stead R. J., Cooke N. J. Adverse effects of inhaled corticosteroids. BMJ. 1989 Feb 18;298(6671):403–404. doi: 10.1136/bmj.298.6671.403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Tan C. Y., Marks R., Payne P. Comparison of xeroradiographic and ultrasound detection of corticosteroid induced dermal thinning. J Invest Dermatol. 1981 Feb;76(2):126–128. doi: 10.1111/1523-1747.ep12525463. [DOI] [PubMed] [Google Scholar]
  18. Tan C. Y., Statham B., Marks R., Payne P. A. Skin thickness measurement by pulsed ultrasound: its reproducibility, validation and variability. Br J Dermatol. 1982 Jun;106(6):657–667. doi: 10.1111/j.1365-2133.1982.tb14702.x. [DOI] [PubMed] [Google Scholar]
  19. Wardman A. G., Simpson F. G., Knox A. J., Page R. L., Cooke N. J. The use of high dose inhaled beclomethasone dipropionate as a means of assessing steroid responsiveness in obstructive airways disease. Br J Dis Chest. 1988 Apr;82(2):168–171. doi: 10.1016/0007-0971(88)90038-1. [DOI] [PubMed] [Google Scholar]
  20. Williams A. J., Baghat M. S., Stableforth D. E., Cayton R. M., Shenoi P. M., Skinner C. Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality. Thorax. 1983 Nov;38(11):813–821. doi: 10.1136/thx.38.11.813. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES